Catalyst Pharmaceuticals (CPRX) Stock Price
$24.58 0.2%
to add to portfolio
AI Score
-
Alternative
6 -
Fundamental
9 -
Technical
6
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Catalyst Pharmaceuticals, AI stock picks, stock alerts and much more.
CPRX AI Stock Analysis
AI stock analysis for CPRX is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Catalyst Pharmaceuticals (CPRX) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Catalyst Pharmaceuticals (CPRX) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Catalyst Pharmaceuticals (CPRX), currently trading at $24.58, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About CPRX
-
Catalyst Pharmaceuticals, Inc.
-
Symbol
CPRX
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
3B
Similar Stocks
 |
Inovio Pharmaceuticals INO |
$2.13 6.5% |
2 |
 |
Moderna MRNA |
$26.93 3.4% |
3 |
 |
Anavex Life Sciences AVXL |
$7.63 0.7% |
6 |
 |
BridgeBio Pharma BBIO |
$33.37 3.4% |
7 |
 |
Crispr Therapeutics CRSP |
$36.78 1.2% |
5 |
News
CPRX Alternative Data
Web Traffic
Catalyst Pharmaceuticals receives an estimated 8823 monthly visitors to catalystpharma.com.
-
Web Traffic
8823
-
Change from Previous Month
0.1%
-
3 Month Change
18.6%
-
YoY Change
18.6%
Twitter Followers
Catalyst Pharmaceuticals has 845 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.6% over the last month.
-
Twitter Followers
845
-
Daily Change
0.1%
-
1 Month Change
0.6%
-
3 Month Change
1%
-
YoY Change
1%
Facebook Engagement
Catalyst Pharmaceuticals has engaged 23 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
23
-
Daily Change
4.2%
-
1 Month Change
109.1%
-
3 Month Change
45.2%
-
YoY Change
45.2%
Reddit Mentions
Catalyst Pharmaceuticals has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Business Outlook
According to employee reviews, the business outlook among employees at Catalyst Pharmaceuticals is 100 out of 100 (very bullish).
-
Business Outlook
100
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
News Mentions
Catalyst Pharmaceuticals was mentioned 1 times in the news yesterday.
-
News Mentions
1
-
Daily Change
66.7%
-
1 Month Change
0%
-
3 Month Change
0%
CPRX Financials
CPRX Key Metrics
-
Total Revenue
$141.8M
-
Net Income
$55.9M
-
Earnings per Share
$0.47
-
Free cash flow
$70.8M
-
EBITDA
$72.3M
-
EBITDA Ratio
0.509808
-
Total Assets
$851.4M
CPRX 2-year Revenue & Income
CPRX 2-year Free Cash Flow
CPRX Technicals
CPRX SMA
CPRX RSI
FAQ
What's the current price of Catalyst Pharmaceuticals (CPRX) Stock?
The price of an Catalyst Pharmaceuticals (CPRX) share is $24.58.
What's the market cap of Catalyst Pharmaceuticals?
The current market cap of Catalyst Pharmaceuticals is 3B.
Should I buy or sell CPRX?
Multiple alternative data signals suggest that Catalyst Pharmaceuticals stock could offer a buying opportunity at its current level, with a reasonable expectation for positive performance in the mid term.
Is Catalyst Pharmaceuticals a good investment?
Based on an in-depth analysis that encompasses fundamentals, technical analysis, and alternative data insights, it appears to be a favorable time to consider investing in Catalyst Pharmaceuticals stock. The bullish indicators suggest that Catalyst Pharmaceuticals' growth prospects and market position may lead to a positive performance in the foreseeable future.
Is now a good time to buy Catalyst Pharmaceuticals (CPRX) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it could be a favorable time to consider buying Catalyst Pharmaceuticals stock, given the bullish outlook.
What are some stocks similar to Catalyst Pharmaceuticals (CPRX) that investors often compare it to?
Catalyst Pharmaceuticals (CPRX) is often compared to similar stocks such as Inovio Pharmaceuticals, Moderna, Anavex Life Sciences, BridgeBio Pharma and Crispr Therapeutics.
What is the forecast for Catalyst Pharmaceuticals' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Catalyst Pharmaceuticals' stock price to be around $26.33 in 2026. Starting from the current price of $24.58, this represents a 7.1% change in price, indicating a bullish outlook for the stock.
How to buy Catalyst Pharmaceuticals (CPRX) Stock?
Catalyst Pharmaceuticals stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Catalyst Pharmaceuticals shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.